Thyrocare Technologies Limited is India's first and foremost advanced fully automated laboratory with a strong presence in over 2000 cities/towns, both nationally and internationally. Thyrocare is unique and focuses on providing quality at affordable costs to laboratories and hospitals, endeavoring to supply cost effective and convenient diagnostic services to every single doorstep.


The headquarters of Thyrocare, also known as Central Processing Laboratory (CPL) is located at Navi Mumbai, India which conducts esoteric tests. We also have Regional Processing Laboratories (RPLs) situated in major metro cities of India and other parts of Asia. We aim to provide advanced technologies, powerful brands and strong systems that enable all laboratories to give their clients the best of science and technology at an affordable cost.

With a belief that 'Quality' is the heart of any intelligent management, Thyrocare has become one of the first Indian diagnostic laboratories to obtain internationally renowned quality accreditations like ISO 9001-2000 rating as early as 2001, which has now upgraded to ISO 9001:2015 and NABL and CAP (College of American Pathologists) accreditations in 2005.

Thyrocare Technologies

CEA -  Carcinoembryonic Antigen

CA 125 - Cancer Antigen 125

CA 15.3 - Cancer Antigen 15.3

AFP - Alpha Fetoprotein

Beta HCG (Quantitative) - Maternal

CBC - Complete Blood Count

CA 19.9 - Cancer Antigen 19.9

ROMA

JAANCH CANCER SCREENING FEMALE ADVANCED

The CEA (Carcinoembryonic Antigen) blood test measures levels of CEA, a protein produced by certain cancerous cells. Elevated CEA levels may indicate the presence of cancers, particularly in the colon, rectum, or other gastrointestinal organs. This test aids in cancer diagnosis, monitoring, and treatment evaluation.

The CA 125 blood test measures Cancer Antigen 125 (CA 125) levels in the blood. CA 125 is a protein marker associated with ovarian cancer, though it can also be elevated in other conditions. Monitoring CA 125 levels aids in diagnosing ovarian cancer, assessing treatment response, and detecting recurrences.

The CBC (Complete Blood Count) blood test evaluates various components of blood, including red blood cells, white blood cells, and platelets. It provides information about overall health, detecting conditions like anemia, infection, and blood disorders, guiding further diagnostic and treatment decisions.

The CA 15-3 blood test measures Cancer Antigen 15-3 (CA 15-3) levels in the blood. CA 15-3 is a tumor marker primarily used to monitor breast cancer progression and treatment response. Elevated CA 15-3 levels may indicate breast cancer recurrence or metastasis, guiding further diagnostic and therapeutic interventions.

AFP (Alpha-fetoprotein) blood test measures the level of AFP in the blood. Elevated AFP levels may indicate liver diseases, certain cancers (such as liver cancer and germ cell tumors), or neural tube defects in infants. It's often used as a tumor marker for diagnosing and monitoring cancers.

The Beta HCG (Quantitative) blood test measures the exact amount of human chorionic gonadotropin (HCG) hormone in the blood. It's used to monitor pregnancy progression, detect abnormalities like ectopic pregnancy, or screen for certain cancers. Quantitative results provide specific HCG levels, aiding in diagnosis and treatment decisions.

The ROMA (Risk of Ovarian Malignancy Algorithm) blood test combines CA-125 levels and HE4 (Human Epididymis Protein 4) to assess the likelihood of ovarian cancer in women with pelvic masses. It aids in the early detection of ovarian cancer and helps guide treatment decisions.

JAANCH CANCER SCREENING FEMALE ADVANCED

About This Test

Thyrocare Technologies

CEA - Carcinoembryonic Antigen -

CA 125 - Cancer Antigen 125 -

CBC - Complete Blood Count -

CA 15.3 - Cancer Antigen 15.3 -

AFP - Alpha Fetoprotein -

CA 19.9 - Cancer Antigen 19.9 -

Beta HCG (Quantitative) - Maternal -

ROMA -

Why choose Curelo?

Your Cart